Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for NEC
Explore 1,257 clinical trials worldwide
Search
Showing 1-50 of 1,257 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: NEC
Clinical Trials (1,257)
NCT06839157
Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer
N/A
Not yet recruiting
4,489 participants
Started: Mar 31, 2027 · Completed: Mar 31, 2028
2 conditions
5 sponsors
0 locations
NCT07175415
HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
PHASE1/PHASE2
Not yet recruiting
42 participants
Started: Oct 1, 2026 · Completed: Oct 1, 2032
5 conditions
3 sponsors
0 locations
NCT07189585
Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis
PHASE2
Not yet recruiting
84 participants
Started: Apr 1, 2026 · Completed: Jul 31, 2027
1 condition
3 sponsors
1 location
NCT07162480
Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
PHASE2
Not yet recruiting
28 participants
Started: Feb 28, 2026 · Completed: Dec 31, 2031
1 condition
2 sponsors
1 location
NCT06743113
Hypoxic Red Blood Cells in Sickle Cell Anemia
NA
Not yet recruiting
48 participants
Started: Jan 31, 2026 · Completed: Jun 30, 2028
4 conditions
6 sponsors
6 locations
NCT07049653
Anifrolumab Pregnancy Study
N/A
Not yet recruiting
627 participants
Started: Jan 31, 2026 · Completed: Dec 10, 2030
1 condition
2 sponsors
0 locations
NCT06659588
Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency
N/A
Not yet recruiting
120 participants
Started: Jan 31, 2026 · Completed: Jan 31, 2028
4 conditions
2 sponsors
3 locations
NCT07161141
Developing an Immersive Virtual Reality Platform
NA
Not yet recruiting
68 participants
Started: Jan 1, 2026 · Completed: Dec 30, 2026
3 conditions
1 sponsor
0 locations
NCT06927648
CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
N/A
Not yet recruiting
130 participants
Started: Dec 31, 2025 · Completed: Feb 28, 2030
1 condition
1 sponsor
0 locations
NCT06908187
Opt-In Early Pilot Study
NA
Not yet recruiting
120 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2028
1 condition
5 sponsors
2 locations
NCT06228352
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
N/A
Not yet recruiting
80 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT06662591
Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study
N/A
Not yet recruiting
3,000 participants
Started: Dec 27, 2025 · Completed: May 27, 2028
1 condition
22 sponsors
20 locations
NCT07214753
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
N/A
Not yet recruiting
335 participants
Started: Dec 19, 2025 · Completed: Dec 31, 2028
1 condition
1 sponsor
28 locations
NCT07215702
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
PHASE2
Not yet recruiting
124 participants
Started: Dec 2, 2025 · Completed: Feb 11, 2027
2 conditions
1 sponsor
61 locations
NCT06683937
Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024
N/A
Not yet recruiting
300 participants
Started: Dec 1, 2025 · Completed: Jun 1, 2026
2 conditions
2 sponsors
16 locations
NCT07205666
The Eplontersen Pregnancy and Lactation Outcomes Study
N/A
Not yet recruiting
10 participants
Started: Nov 30, 2025 · Completed: Dec 30, 2035
1 condition
2 sponsors
0 locations
NCT06728410
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
PHASE2
Not yet recruiting
38 participants
Started: Nov 30, 2025 · Completed: Jul 31, 2027
3 conditions
4 sponsors
1 location
NCT07213804
A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
PHASE3
Not yet recruiting
1,080 participants
Started: Nov 30, 2025 · Completed: Aug 31, 2031
4 conditions
4 sponsors
39 locations
NCT07069595
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
PHASE2
Not yet recruiting
78 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2028
4 conditions
3 sponsors
1 location
NCT06998095
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
N/A
Not yet recruiting
150 participants
Started: Nov 30, 2025 · Completed: Oct 31, 2029
1 condition
1 sponsor
0 locations
NCT07156877
Assessment of Pulmonary Vein Isolation Using a Balloon Catheter With Pulsed Field Energy in Atrial Fibrillation
NA
Not yet recruiting
136 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2028
1 condition
1 sponsor
2 locations
NCT06408389
Mechanics of Human Pre Implantation Development
N/A
Not yet recruiting
1,500 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2028
1 condition
5 sponsors
0 locations
NCT06588621
HEalthCAre Workers' Health: a Transversal Evaluation
N/A
Not yet recruiting
450 participants
Started: Nov 30, 2025 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT07218809
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
PHASE3
Not yet recruiting
1,100 participants
Started: Nov 28, 2025 · Completed: May 27, 2030
1 condition
4 sponsors
0 locations
NCT07000110
Anifrolumab Malignancy and Serious Infections Study
N/A
Not yet recruiting
3,506 participants
Started: Nov 28, 2025 · Completed: Nov 30, 2031
1 condition
2 sponsors
0 locations
NCT07201558
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
PHASE1
Not yet recruiting
48 participants
Started: Nov 28, 2025 · Completed: Jun 27, 2028
2 conditions
1 sponsor
0 locations
NCT06705764
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
PHASE4
Not yet recruiting
100 participants
Started: Nov 24, 2025 · Completed: Nov 30, 2026
1 condition
2 sponsors
2 locations
NCT07073950
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD)
PHASE4
Not yet recruiting
56 participants
Started: Nov 14, 2025 · Completed: Mar 31, 2027
2 conditions
2 sponsors
0 locations
NCT07088926
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
PHASE2
Not yet recruiting
435 participants
Started: Nov 12, 2025 · Completed: Jun 14, 2028
1 condition
1 sponsor
18 locations
NCT07216131
A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years
PHASE1
Not yet recruiting
14 participants
Started: Nov 10, 2025 · Completed: Dec 29, 2025
1 condition
2 sponsors
0 locations
NCT07128407
PMT-Based Radiation Safety Training for Nurses: Randomized Controlled Trial.
NA
Not yet recruiting
54 participants
Started: Nov 7, 2025 · Completed: Mar 7, 2026
1 condition
1 sponsor
1 location
NCT07155226
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
PHASE1/PHASE2
Not yet recruiting
84 participants
Started: Nov 3, 2025 · Completed: Jun 18, 2029
3 conditions
1 sponsor
13 locations
NCT07215585
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
PHASE3
Not yet recruiting
420 participants
Started: Nov 2, 2025 · Completed: Jul 29, 2033
1 condition
1 sponsor
24 locations
NCT07213986
Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction
NA
Recruiting
12 participants
Started: Nov 1, 2025 · Completed: Mar 1, 2026
2 conditions
2 sponsors
1 location
NCT07160751
Cognition and Patients With Lung Cancer
N/A
Not yet recruiting
90 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
1 condition
2 sponsors
1 location
NCT06815211
The German National CRS Registry (GenreCRS): Clinical Evaluation of the New European Academy for Allergy and Clinical Immunology (EAACI) Criteria for CRSwNP Disease Control, Remission and Cure in a Real-World Evidence Study Approach
N/A
Not yet recruiting
500 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
2 conditions
2 sponsors
0 locations
NCT07109219
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
PHASE1/PHASE2
Not yet recruiting
83 participants
Started: Oct 31, 2025 · Completed: Jul 3, 2028
1 condition
2 sponsors
22 locations
NCT07022483
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
PHASE3
Not yet recruiting
710 participants
Started: Oct 31, 2025 · Completed: Mar 23, 2032
1 condition
2 sponsors
0 locations
NCT07064005
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
PHASE1
Not yet recruiting
12 participants
Started: Oct 31, 2025 · Completed: Nov 27, 2027
1 condition
2 sponsors
1 location
NCT07218536
The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in Egypt
N/A
Not yet recruiting
200 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
1 condition
1 sponsor
0 locations
NCT07123454
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
PHASE1/PHASE2
Not yet recruiting
91 participants
Started: Oct 31, 2025 · Completed: Mar 1, 2028
1 condition
1 sponsor
17 locations
NCT06594068
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
PHASE4
Recruiting
16 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
1 condition
2 sponsors
1 location
NCT07215026
Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes
N/A
Not yet recruiting
800 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
0 locations
NCT06519734
Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products
N/A
Not yet recruiting
200 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT07173933
Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)
PHASE1/PHASE2
Not yet recruiting
15 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
1 condition
1 sponsor
1 location
NCT06312943
"Translating Articular Biomarkers Into Diagnoses"
N/A
Not yet recruiting
50 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2029
1 condition
3 sponsors
1 location
NCT06582173
Mapping the Healthcare Pathway to Multidisciplinary Assessment of 12-25 Year Olds With Somatic Symptom Disorder
N/A
Not yet recruiting
36 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
3 conditions
2 sponsors
1 location
NCT06798532
Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors
N/A
Not yet recruiting
150 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2026
3 conditions
2 sponsors
27 locations
NCT07013006
Retrospective Study to Assess the Evolution of MRI or CT Lesions in Treated CNS Nocardiosis
N/A
Not yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2026
1 condition
2 sponsors
14 locations
NCT07170826
Evaluation of a Therapeutic Education Program on Self-image in Patients With Chronic Inflammatory Rheumatic Diseases
N/A
Not yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
1 condition
2 sponsors
1 location
«
Previous
1
2
2
3
4
More pages
26
Next